Data Leak Alert: Social media users have been actively discussing a reported data breach involving McKesson Corporation, highlighting potential risks to sensitive information in the healthcare sector. Analysts note that such incidents could prompt closer scrutiny from regulators and impact operational trust among partners.
Market Position: Conversations emphasize McKesson's role in the concentrated U.S. pharmaceutical distribution landscape alongside peers, with participants comparing valuation metrics like forward price-to-earnings ratios. This focus underscores ongoing interest in the company's efficiency as a key intermediary in drug supply chains.
Technical Outlook: Traders are pointing to chart patterns showing compression in McKesson's price action, suggesting possible volatility ahead with levels eyed for potential moves. Overall sentiment remains mixed as observers weigh these developments against broader sector trends.
Note: This discussion summary was generated from an AI condensation of post data.
McKesson Insider Trading Activity
McKesson insiders have traded $MCK stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $MCK stock by insiders over the last 6 months:
- BRIAN S. TYLER (Chief Executive Officer) has made 0 purchases and 3 sales selling 21,855 shares for an estimated $17,036,650.
- MICHELE LAU (EVP and Chief Legal Officer) sold 3,550 shares for an estimated $2,701,869
- THOMAS L RODGERS (EVP, Chief Strategy & BDO) has made 0 purchases and 3 sales selling 3,210 shares for an estimated $2,421,903.
- LEANN B SMITH (EVP & Chief HR Officer) sold 1,810 shares for an estimated $1,331,255
- BRADLEY E LERMAN sold 301 shares for an estimated $268,589
- NAPOLEON B JR RUTLEDGE (SVP, Controller & CAO) sold 133 shares for an estimated $101,612
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
McKesson Revenue
McKesson had revenues of $105.4B in Q1 2027. This is an increase of 7.72% from the same period in the prior year.
You can track MCK financials on Quiver Quantitative's MCK stock page.
You can access data on MCK stock through the Quiver Quantitative API.
McKesson Congressional Stock Trading
Members of Congress have traded $MCK stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $MCK stock by members of Congress over the last 6 months:
- REPRESENTATIVE RICK LARSEN purchased up to $15,000 on 07/08.
- REPRESENTATIVE JONATHAN L. JACKSON sold up to $15,000 on 06/15.
- REPRESENTATIVE LIZZIE FLETCHER sold up to $15,000 on 04/08.
- SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
McKesson Hedge Fund Activity
We have seen 861 institutional investors add shares of McKesson stock to their portfolio, and 1,078 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY added 3,006,517 shares (+130.7%) to their portfolio in Q2 2026, for an estimated $2,271,724,245
- JPMORGAN CHASE & CO added 1,748,860 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,321,438,616
- FMR LLC removed 1,473,135 shares (-40.9%) from their portfolio in Q2 2026, for an estimated $1,113,100,806
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 993,404 shares (+inf%) to their portfolio in Q2 2026, for an estimated $750,616,062
- JANE STREET GROUP, LLC added 666,328 shares (+825.4%) to their portfolio in Q2 2026, for an estimated $503,477,436
- BLACKROCK, INC. removed 623,330 shares (-5.5%) from their portfolio in Q2 2026, for an estimated $470,988,148
- ALLIANCEBERNSTEIN L.P. removed 553,704 shares (-24.7%) from their portfolio in Q2 2026, for an estimated $418,378,742
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
McKesson Government Contracts
We have seen $12,586,732,128 of award payments to $MCK over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 APRIL: $1,191,348,080
- EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER: $1,184,200,532
- EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MARCH: $1,175,683,450
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
McKesson Analyst Ratings
Wall Street analysts have issued reports on $MCK in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 04/28/2026
To track analyst ratings and price targets for McKesson, check out Quiver Quantitative's $MCK forecast page.
McKesson Price Targets
Multiple analysts have issued price targets for $MCK recently. We have seen 7 analysts offer price targets for $MCK in the last 6 months, with a median target of $945.0.
Here are some recent targets:
- Glen Santangelo from Barclays set a target price of $925.0 on 06/10/2026
- Daniel Grosslight from Citigroup set a target price of $945.0 on 05/14/2026
- Stephen Baxter from Wells Fargo set a target price of $812.0 on 05/12/2026
- Elizabeth Anderson from Evercore ISI Group set a target price of $850.0 on 05/08/2026
- Lisa Gill from JP Morgan set a target price of $1015.0 on 05/08/2026
- Kevin Caliendo from UBS set a target price of $1050.0 on 05/08/2026
- Michael Cherny from B of A Securities set a target price of $1000.0 on 04/06/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
